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Tropomyosin is a highly conserved actin-binding protein that is found in most
eukaryotic cells. It is critical for actin-filament stabilization and for cooperative
regulation of many actin functions. Detailed structural information on tropo-
myosin is very important in order to understand the mechanisms of its action.
Whereas structures of isolated tropomyosin fragments have been obtained at
high resolution, the atomic structure of the entire tropomyosin molecule is still
unknown. Here, the crystallization and preliminary crystallographic analysis of
full-length yeast tropomyosin 2 (yTm2) from Saccharomyces cerevisiae are
reported. Recombinant yTm2 expressed in Escherichia coli was crystallized
using the hanging-drop vapour-diffusion method. The crystals belonged to space
group C2, with unit-cell parameters a = 154.8, b = 49.9, c = 104.0 A˚,  =  = 90.0,
 = 124.0 and two molecules in the asymmetric unit. A complete native X-ray
diffraction data set was collected to 3.5 A˚ resolution using synchrotron
radiation.
1. Introduction
Tropomyosin is a highly conserved actin-binding protein that is pre-
sent in most eukaryotic cells. It is an -helical coiled-coil dimer that
forms a head-to-tail polymer along the length of the actin filament.
The most studied role of tropomyosin is in vertebrate skeletal and
cardiac muscles, where it is involved in the regulation of muscle
contraction through interactions with troponin and actin (reviewed
by Brown & Cohen, 2005).
Saccharomyces cerevisiae has two tropomyosin isoforms, yTm1 and
yTm2, which are encoded by two separate genes, TPM1 and TPM2,
with yTm1 being about six times more abundant than yTm2 (Liu &
Bretscher, 1989; Drees et al., 1995). The yeast tropomyosins are the
shortest to be identified to date, comprising 199 and 161 amino acids,
respectively, equivalent to five and four actin-binding sites. All other
tropomyosin isoforms currently identified have either 248 or 284
residues, spanning six or seven actin molecules, respectively.
Nonmuscle tropomyosin is believed to play an important role in
stabilizing the actin cytoskeleton (Gunning et al., 2005). Previous
studies have shown that the simultaneous deletion of both tropo-
myosin genes in S. cerevisiae results in lethality, whereas disruption of
the TPM1 gene alone results in a temperature-sensitive phenotype
and the disappearance of actin cables. This phenotype can be partially
rescued by overexpression of the TPM2 gene. Loss of yTm2 has no
detectable phenotype (Drees et al., 1995). Thus, the two proteins
participate in the performance of some essential function in yeast.
However, they seem to be functionally distinct.
It is widely believed that tropomyosin adopts a flexible rod-like
structure and that this flexibility plays a crucial role in its functions.
This high flexibility makes crystallization of full-length tropomyosin
an extremely difficult task. Full-length tropomyosin formed crystals
that diffracted X-rays poorly (Phillips et al., 1986; Whitby et al., 1992)
and the structure has only been obtained at 7 A˚ resolution at best
(Whitby & Phillips, 2000). High-resolution structures have only been
obtained for isolated fragments of muscle tropomyosin stabilized
either by a GCN4 leucine-zipper extension or by disulfide bonds
between cysteine residues introduced at the end of the coiled coil
# 2008 International Union of Crystallography
All rights reserved
(Greenfield et al., 1998, 2003, 2006; Brown et al., 2001, 2005; Li et al.,
2002; Nitanai et al., 2007).
In the atomic structure of an N-terminal fragment comprising 81
residues, specific regions have been identified in which consecutive
alanine or serine residues are clustered at the hydrophobic core of the
coiled coil. At the boundary of the alanine cluster, two paired chains
are staggered with respect to each other, giving rise to a bend in the
tropomyosin coiled coil (Brown et al., 2001). These regions could
provide the flexibility in the tropomyosin strand that is required for
winding around the actin filament as well as for the regulation of
muscle contraction. Neither yTm1 nor yTm2 contain such alanine
clusters. Unlike muscle tropomyosins, the coiled coils of the tropo-
myosin from S. cerevisiae are probably not continuous. They seem to
be interrupted at one position in yTm2 and two positions in yTm1;
the phase of the heptad repeats shifts owing to a four-residue deletion
(Strand et al., 2001). It was suggested that these shifts might induce
the bends in the yeast tropomyosin molecules. Thus, judging from the
amino-acid sequence, the structure of yeast tropomyosin may differ
from the structure of muscle tropomyosin.
To date, only the structure of muscle tropomyosin has been
investigated intensively. Structural information on nonmuscle
tropomyosin still remains completely unknown. In this paper, we
report the crystallization and preliminary X-ray crystallographic
analysis of full-length nonmuscle yeast tropomyosin 2 from S. cere-
visiae.
2. Experimental procedures and results
2.1. Expression and purification
The yTm2 construct in pJC20 vector (Maytum et al., 2001) was
transformed into competent Escherichia coli cells [strain BL21 (DE3)
pLys S] and expressed and purified as described previously (Maytum
et al., 2000) with modifications. Briefly, a 2 l culture was grown at
310 K to late exponential phase in Luria–Bertani medium, induced
with 0.5 mM isopropyl -d-1-thiogalactopyranoside and grown at
310 K for a further 4 h. The cell pellet was suspended in lysis buffer
consisting of 20 mM Tris–HCl pH 7.4, 100 mM NaCl, 2 mM EDTA,
lysed by sonication and heated at 353 K for 15 min. Precipitated
proteins and cell debris were removed by centrifugation. Tropo-
myosin was then isoelectrically precipitated from the supernatant at
pH 4.5. The precipitate was pelleted, resuspended in 40–50 ml
running buffer (20 mM potassium phosphate pH 7.0, 100 mM NaCl)
and applied onto a MonoQ HR column (GE Healthcare). The
column was washed with a linear gradient of NaCl from 0.1 to 0.4M
in 20 mM potassium phosphate pH 7.0. The primary product con-
taining the target protein was then applied onto CHT Ceramic
Hydroxyapatite Type I (Bio-Rad) equilibrated with 10 mM potassium
phosphate pH 7.0, 300 mMNaCl. The protein was eluted with a linear
gradient of 10–500 mM potassium phosphate pH 7.0. Finally, tropo-
myosin was further purified on a HiTrap Phenyl HP column (GE
Healthcare) with a linear gradient of 1.7–0.8M ammonium sulfate in
10 mM Tris–HCl pH 7.0. The purity of the protein was examined by
SDS–PAGE with Coomassie Brilliant Blue staining. Purified protein
was dialyzed extensively against 10 mM Tris–HCl pH 7.0 and con-
centrated to 5–10 mg ml1 using Centricon YM-10 (Millipore
Corporation).
2.2. Crystallization
Initial crystallization experiments were performed using the
hanging-drop vapour-diffusion method at three different tempera-
tures (278, 286 and 293 K) in VDX plates (Hampton Research). The
crystallization screening kits Crystal Screen, Crystal Screen 2 and
Crystal Screen Cryo (Hampton Research) were used as initial
screening conditions. 2 ml protein solution was mixed with an equal
volume of precipitant solution and equilibrated against a 1 ml
reservoir. Rod-like crystals of yeast tropomyosin 2 were obtained in
Crystal Screen 2 condition No. 4 [35%(v/v) dioxane] at 286 K. The
crystals diffracted to a maximum resolution of only 10 A˚. To improve
the crystal quality, the initial crystallization condition was further
optimized by varying the additives and the concentrations of preci-
pitant and protein. We found that in the presence of taurine yTm2
gave crystals of a completely different shape (Fig. 1). These crystals
diffracted to 3.2 A˚ resolution. The crystals were obtained at 286 K in
a drop containing 10 mM Tris–HCl pH 7.0, 15 mM taurine, 0.1%(w/v)
n-octyl -d-glucoside and 2 mg ml1 protein that was equilibrated
against 1 ml 25%(v/v) dioxane. The crystals appeared after 5–6 d and
reached maximum dimensions of 0.6  0.2  0.02 mm in about 10 d.
2.3. X-ray diffraction data collection and processing
X-ray diffraction data were collected on RIKEN Structural
Biology Beamline II (BL44B2) at SPring-8 using an ADSC Quantum
210 CCD detector (Area Detector Systems Corporation; Adachi et
al., 2001). Before collecting diffraction data, crystals were soaked for
20 min in cryoprotectant solution containing 80 mM Tris–HCl pH 7.0,
100 mM taurine, 15%(v/v) dioxane and 30%(w/v) ethylene glycol.
Subsequently, crystals were mounted in a nylon loop (Hampton
Research) and flash-cooled in a nitrogen stream at 100 K. Diffraction
spots were indexed, integrated and scaled using the HKL-2000
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Figure 1
Crystals of yeast tropomyosin 2 from S. cerevisiae with dimensions of 0.6  0.2 
0.02 mm.
Table 1
Diffraction data statistics for the native crystal of yTm2.
Values in parentheses are for the highest resolution shell.
Space group C2
Unit-cell parameters (A˚, ) a = 154.8, b = 49.9, c = 104.0,
 =  = 90.0,  = 124.0
Wavelength (A˚) 1.0000
Resolution (A˚) 50–3.5 (3.63–3.5)
Completeness (%) 100 (89.64)
Total reflections 50357
Unique reflections 13885
Redundancy 3.7 (3.4)
Rmerge(I)† (%) 6.2 (24.5)
Mean I/(I) 14.1 (4.2)
† Rmerge(I) =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity
of the ith observation of reflection hkl.
package (Otwinowski & Minor, 1997). The crystals diffracted to
beyond 3.2 A˚ resolution and belonged to space group C2. The unit-
cell parameters were a = 154.8, b = 49.9, c = 104.0 A˚,  =  = 90.0,
 = 124.0. Assuming the presence of two molecules per asymmetric
unit, the calculated Matthews coefficient (Matthews, 1968) was
2.18 A˚3 Da1, which corresponds to a solvent content of 43.6%. A
complete native X-ray diffraction data set was successfully collected
at 3.5 A˚ resolution using synchrotron radiation. Data-collection
statistics are summarized in Table 1.
This work was supported by an ERATO grant from the Japan
Science and Technology Agency.
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